NCT05967416 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05967416
Title	Phase 1, Open-Label Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	SIRPant Immunotherapeutics, Inc.
Indications	mycosis fungoides chronic lymphocytic leukemia/small lymphocytic lymphoma angioimmunoblastic T-cell lymphoma Sezary's disease peripheral T-cell lymphoma primary cutaneous T-cell non-Hodgkin lymphoma marginal zone lymphoma nodal marginal zone lymphoma adult T-cell leukemia/lymphoma mantle cell lymphoma diffuse large B-cell lymphoma follicular lymphoma anaplastic large cell lymphoma
Therapies	SIRPant-M
Age Groups:	adult \| senior
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
City of Hope	RECRUITING	Duarte	California	91010	United States	Details
Hackensack University Medical Center	RECRUITING	Hackensack	New Jersey	07601	United States	Details
MD Anderson Cancer Center	RECRUITING	Houston	Texas	77030	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT05967416Clinical Trial Detail